Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease–Associated Hepatocellular Carcinoma in the United States

Keyphrases

• United States 100%
• Non-alcoholic Fatty Liver Disease (NAFLD) 100%
• Clinical Outcomes 100%
• Clinical Characteristics 100%
• Hepatocellular Carcinoma 100%
• Overall Survival 45%
• Etiology 27%
• Confidence Interval 27%
• Curative Treatment 27%
• Hepatocellular Carcinoma Surveillance 27%
• Early Hepatocellular Carcinoma 18%
• Liver Disease 18%
• Adjusted Odds Ratio 18%
• Disease-related 18%
• Hepatocellular Carcinoma Patients 18%
• Early-stage Detection 18%
• Tumor Stage 9%
• Clinical Presentation 9%
• Surveillance Epidemiology 9%
• Hepatitis 9%
• Ascites 9%
• Contemporary Practice 9%
• Subgroup Analysis 9%
• Cox Regression 9%
• Poor Survival 9%
• Tumor Detection 9%
• Adjusted Hazard Ratio 9%
• Multivariable Logistic Regression 9%
• Hepatic Encephalopathy 9%
• Early Tumor 9%
• Multifaceted Intervention 9%
• Medicare Beneficiaries 9%
• Treatment Receipt 9%

Medicine and Dentistry

• Hepatocellular Carcinoma 100%
• Nonalcoholic Fatty Liver 100%
• Overall Survival 38%
• Cancer Staging 15%
• Odds Ratio 15%
• Liver Disease 15%
• Cohort Effect 7%
• Prevalence 7%
• Proportional Hazards Model 7%
• Logistic Regression Analysis 7%
• Medicare 7%
• Hazard Ratio 7%
• Ascites 7%
• Subgroup Analysis 7%
• Hepatic Encephalopathy 7%

Pharmacology, Toxicology and Pharmaceutical Science

• Nonalcoholic Fatty Liver 100%
• Liver Cell Carcinoma 100%
• Overall Survival 38%
• Liver Disease 15%
• Cancer Staging 15%
• Prevalence 7%
• Ascites 7%
• Hepatic Encephalopathy 7%